Hudson Bay Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Hudson Bay Capital Management's LLY Position: Q2 2026 in Review
Hudson Bay Capital Management increased its Eli Lilly (LLY) stake by 49% in Q2 2026, buying an estimated $33.7M and bringing the position to 100,000 shares worth $120M. The position accounts for 0.33% of the portfolio, ranked #70.
Hudson Bay Capital Management first reported a position in LLY in Q1 2021 and has held it in 14 quarters since. The position peaked at $353M in Q2 2024. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Hudson Bay Capital Management held 100,000 shares of Eli Lilly worth $120M as of Q2 2026.
- Hudson Bay Capital Management bought 32,996 Eli Lilly shares in Q2 2026, an estimated $33.7M.
- Eli Lilly made up 0.33% of Hudson Bay Capital Management's portfolio in Q2 2026, its #70 holding.
- Hudson Bay Capital Management first reported a position in Eli Lilly in Q1 2021 and has held it in 14 quarters since.
- Hudson Bay Capital Management's Eli Lilly position peaked at $353M in Q2 2024.
- 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.